Show Cart

More News

18 Aug 2018 HitGen Announces Innovative Drug Discovery Research Collaboration with LG Chem by Applying DNA-Encoded Technology
17 Aug 2018 Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins
15 Aug 2018 RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality and Persistence of T Cells and NK Cells for the Advancement of Immuno-Oncology Therapeutics for Solid Tumors
15 Aug 2018 Haplogen enters into a collaboration with Bayer
13 Aug 2018 Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax
13 Aug 2018 Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis
13 Aug 2018 Mustang Bio and St. Jude Children’s Research Hospital Enter into Exclusive Worldwide License Agreement for a Ground-Breaking, Clinical-Stage Lentiviral Gene Therapy with Curative Potential for X-linked Severe Combined Immunodeficiency
11 Aug 2018 Astellas Announces Acquisition of Quethera
10 Aug 2018 OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
09 Aug 2018 Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash
09 Aug 2018 Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple CNS-targeted Gene Therapy programs and Access to Important Gene Therapy Talent and Tools
09 Aug 2018 Ambys Medicines and Takeda Announce Partnership to Pioneer First-In-Class Therapies for the Treatment of Serious Liver Diseases
07 Aug 2018 Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101
07 Aug 2018 Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies
06 Aug 2018 Regeneron and bluebird bio Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer
06 Aug 2018 Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form Partnership to Develop a Novel Gene Therapy Treatment for Cystic Fibrosis
06 Aug 2018 Inovio Partners with AIDS Malignancy Consortium to Advance Inovio’s HPV Therapy for High-Grade Anal Dysplasia in HIV-positive Patients
02 Aug 2018 Laekna Acquires Exclusive Worldwide Rights to Two Clinical Stage Oncology Assets
02 Aug 2018 Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate
31 Jul 2018 GeoVax and Emory University to Collaborate On HPV Therapeutic Program for Head and Neck Cancers
30 Jul 2018 Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
30 Jul 2018 Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
26 Jul 2018 I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies
25 Jul 2018 Alector Announces $133 Million in Series E Financing to Advance Broad Portfolio of Immuno-Neurology and Immuno-Oncology Programs
25 Jul 2018 GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top